Results 151 to 160 of about 7,602 (197)

Controlled access to lumasiran in primary hyperoxaluria type 1: evaluation of a new access route for orphan drugs in the Netherlands. [PDF]

open access: yesNephrol Dial Transplant
Deesker LJ   +9 more
europepmc   +1 more source

Tailored Kidney Stone Prevention Improves Metabolic Risk Factors and Reduces Renal Colic Rate. [PDF]

open access: yesKidney Int Rep
Van de Perre E   +14 more
europepmc   +1 more source

Improved 24-hour urine parameters associated with reduced symptomatic kidney stone recurrence. [PDF]

open access: yesUrolithiasis
Sui W   +6 more
europepmc   +1 more source

A novel synbiotic formulation prevents calcium oxalate stones by restoring gut microbiota homeostasis. [PDF]

open access: yesBMC Microbiol
Li XM   +9 more
europepmc   +1 more source

[Primary hyperoxaluria].

open access: yesSrpski arhiv za celokupno lekarstvo, 1979
S, Berger   +4 more
openaire   +1 more source

Treatment preferences among individuals with primary hyperoxaluria type 1 (PH1): a real-world study. [PDF]

open access: yesOrphanet J Rare Dis
Goldfarb DS   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy